Michael Kiernan to Cyclic Nucleotide Phosphodiesterases, Type 5
This is a "connection" page, showing publications Michael Kiernan has written about Cyclic Nucleotide Phosphodiesterases, Type 5.
Connection Strength
0.374
-
Grandin EW, Gulati G, Nunez JI, Kennedy K, Rame JE, Atluri P, Pagani FD, Kirklin JK, Kormos RL, Teuteberg J, Kiernan MS. Outcomes With Phosphodiesterase-5 Inhibitor Use After Left Ventricular Assist Device: An STS-INTERMACS Analysis. Circ Heart Fail. 2022 04; 15(4):e008613.
Score: 0.198
-
Gulati G, Kiernan MS. Phosphodiesterase-5 Inhibitor Therapy for Left Ventricular Assist Device Patients: More Data, More Questions. J Am Heart Assoc. 2020 07 21; 9(14):e017585.
Score: 0.176